FTC hits Amneal, Impax and Endo with antitrust suit
28-01-2021
Amneal and Impax merge to become ‘fifth largest’ generics company
19-10-2017
Allergan settles Restasis patent suit with InnoPharma, leaving three defendants
13-10-2017
Jirsak / shutterstock.com
Dublin-based pharmaceutical company Allergan has revealed that its subsidiaries, Forest Laboratories and Adamas Pharmaceuticals, have entered into a settlement agreement with Amneal Pharmaceuticals.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Allergan, Adamas, Amneal, Forest, Namzaric, FDA, ANDA, patent
